HCP, Inc. (NYSE:HCP) – Equities researchers at Jefferies Group dropped their FY2019 EPS estimates for shares of HCP in a note issued to investors on Wednesday, May 16th. Jefferies Group analyst O. Okusanya now forecasts that the real estate investment trust will earn $1.83 per share for the year, down from their prior forecast of $1.84. Jefferies Group currently has a “Hold” rating and a $26.00 target price on the stock.

Other analysts also recently issued reports about the company. Bank of America upgraded HCP from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $22.63 to $25.00 in a research report on Thursday, March 8th. Mizuho set a $26.00 target price on HCP and gave the stock a “buy” rating in a research report on Thursday, February 15th. Stifel Nicolaus reiterated a “buy” rating and set a $27.00 target price (down from $29.00) on shares of HCP in a research report on Wednesday, February 14th. Robert W. Baird set a $24.00 target price on HCP and gave the stock a “hold” rating in a research report on Thursday, February 15th. Finally, BMO Capital Markets set a $25.00 target price on HCP and gave the stock a “hold” rating in a research report on Tuesday, February 13th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the stock. HCP presently has an average rating of “Hold” and a consensus price target of $27.15.

NYSE:HCP opened at $23.14 on Friday. HCP has a twelve month low of $23.28 and a twelve month high of $23.68. The firm has a market cap of $10.96 billion, a PE ratio of 11.87, a price-to-earnings-growth ratio of 4.29 and a beta of 0.24. The company has a quick ratio of 0.15, a current ratio of 0.15 and a debt-to-equity ratio of 1.25.

HCP (NYSE:HCP) last released its earnings results on Thursday, May 3rd. The real estate investment trust reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.38). HCP had a negative return on equity of 0.13% and a negative net margin of 0.41%. The business had revenue of $479.20 million for the quarter, compared to the consensus estimate of $452.86 million. During the same quarter last year, the business posted $0.51 earnings per share. The firm’s revenue for the quarter was down 2.7% compared to the same quarter last year.

Institutional investors have recently made changes to their positions in the company. Vestpro Financial Partners Inc. dba CPF Texas purchased a new position in HCP in the fourth quarter valued at about $103,000. Archford Capital Strategies LLC purchased a new position in HCP in the first quarter valued at about $167,000. Ellington Management Group LLC purchased a new position in HCP in the fourth quarter valued at about $232,000. Cullen Frost Bankers Inc. purchased a new position in HCP in the fourth quarter valued at about $244,000. Finally, Advisor Partners LLC purchased a new position in HCP in the first quarter valued at about $228,000. Hedge funds and other institutional investors own 90.46% of the company’s stock.

In other news, Director R Kent Griffin, Jr. purchased 21,100 shares of the business’s stock in a transaction dated Monday, May 14th. The shares were purchased at an average price of $23.80 per share, for a total transaction of $502,180.00. Following the completion of the purchase, the director now owns 30,575 shares in the company, valued at approximately $727,685. The purchase was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.14% of the company’s stock.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 22nd. Stockholders of record on Monday, May 7th will be paid a dividend of $0.37 per share. The ex-dividend date is Friday, May 4th. This represents a $1.48 annualized dividend and a dividend yield of 6.40%. HCP’s dividend payout ratio is currently 75.90%.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Earnings History and Estimates for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.